Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kotra Industries BhdXKLS:0002 83 5-Year Yield-on-Cost % is 25.23 as of Jul. 16, 2026, which is 84% above its 10-year median of 13.70. GuruFocus rates XKLS:0002 with a GF Score™ of 83/100 and a GF Value™ of RM4.34 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 514 Drug Manufacturers companies, Kotra Industries Bhd ranks better than 96.5% on this metric.
Kotra Industries Bhd's yield on cost for the quarter that ended in Mar. 2026 was 25.23.
The historical rank and industry rank for Kotra Industries Bhd's 5-Year Yield-on-Cost % or its related term are showing as below:
XKLS:0002'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 3.94 Med: 13.7 Max: 40.79
Current: 25.23
During the past 13 years, Kotra Industries Bhd's highest Yield on Cost was 40.79. The lowest was 3.94. And the median was 13.70.
XKLS:0002's 5-Year Yield-on-Cost % is ranked better than 96.5% of 514
companies
in the Drug Manufacturers industry
Industry Median: 2.3
vs XKLS:0002: 25.23
Kotra Industries Bhd (XKLS:0002) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Kotra Industries Bhd 5-Year Yield-on-Cost % Related Terms
XKLS:0002 vs ZTS, UTHR, VTRS: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Kotra Industries Bhd's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kotra Industries Bhd 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kotra Industries Bhd's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Kotra Industries Bhd's 5-Year Yield-on-Cost % falls into.
Kotra Industries Bhd 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Kotra Industries Bhd (XKLS:0002) has a 5-Year Yield-on-Cost % of 25.23 as of Jul. 16, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Kotra Industries Bhd and its competitors. This is 84% above median its historical median of 13.70. Over the past decade, Kotra Industries Bhd's 5-Year Yield-on-Cost % has ranged from 3.94 to 40.79. According to the industry distribution chart, Kotra Industries Bhd ranks #18 out of 514 companies in the Drug Manufacturers industry, placing it in the top 3.5%.
Is Kotra Industries Bhd's 5-Year Yield-on-Cost % too high?
Kotra Industries Bhd's current 5-Year Yield-on-Cost % of 25.23 is 84% above median its 10-year median of 13.70. Over the past 10 years, this metric has ranged from a low of 3.94 to a high of 40.79. The Drug Manufacturers industry median 5-Year Yield-on-Cost % is 2.30. Kotra Industries Bhd's value of 25.23 is 997% above this industry median. Based on the distribution chart, Kotra Industries Bhd ranks #18 out of 514 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Kotra Industries Bhd has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kotra Industries Bhd's 5-Year Yield-on-Cost % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kotra Industries Bhd ranks #18 out of 514 companies for 5-Year Yield-on-Cost %. This places Kotra Industries Bhd in the top 4% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.30. Kotra Industries Bhd's value of 25.23 is 997% above this benchmark. Historically, Kotra Industries Bhd's own 5-Year Yield-on-Cost % has ranged from 3.94 to 40.79 over the past decade. While the company's 10-year median is 13.70 vs. the industry median of 2.30, Kotra Industries Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.30, based on 514 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kotra Industries Bhd's current 5-Year Yield-on-Cost % of 25.23 is 997% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Kotra Industries Bhd and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kotra Industries Bhd's current 5-Year Yield-on-Cost % is 25.23, which is 84% above median its own 10-year median of 13.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kotra Industries Bhd stock overvalued right now?
Based on GuruFocus' analysis, Kotra Industries Bhd (XKLS:0002) is currently considered Modestly Undervalued. The stock's GF Value™ is RM4.34, compared to a current price of RM3.70 — trading 14.7% below its estimated fair value. The current 5-Year Yield-on-Cost % is 25.23, which is 84% above median its 10-year median of 13.70 and 997% above the Drug Manufacturers industry median of 2.30. Kotra Industries Bhd's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Kotra Industries Bhd (XKLS:0002), the current 5-Year Yield-on-Cost % is 25.23 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kotra Industries Bhd (XKLS:0002) Overvalued in 2026?
Based on GuruFocus' analysis, Kotra Industries Bhd stock appears to be undervalued.
The current stock price of RM3.70 is trading 14.7% below its estimated GF Value™ of RM4.34.
GuruFocus considers Kotra Industries Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0002:
5-Year Yield-on-Cost %: 25.23 (84% above median its 10-year median of 13.70)
GF Value™: RM4.34 vs. price of RM3.70 (14.7% below fair value)
Industry Position: 997% above the Drug Manufacturers median (#18 of 514)
No single metric tells the full story. See the XKLS:0002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kotra Industries Bhd is a Malaysian pharmaceutical company engaged in the development, manufacturing, and supply of pharmaceutical and healthcare products supporting all life stages. Its portfolio includes life-saving medicines, OTC supplements, and nutrition products. The Group markets three core brands: Appeton, offering health supplements and nutrition across all age groups; Vaxcel, providing injectable medicines for infectious diseases, kidney care, and gastroenterology; and Axcel, specializing in oral and topical medicines for paediatrics, dermatology, and infectious diseases. The company operates in Malaysia and overseas, with the majority of revenue derived from Malaysia.
83GF Score
Get the complete analysis for XKLS:0002
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0002 has been successfully added to your 
